Efficiency of laser-assisted intracytoplasmic sperm injection in a human assisted reproductive techniques program
- PMID: 22384434
- PMCID: PMC3283067
- DOI: 10.5653/cerm.2011.38.3.148
Efficiency of laser-assisted intracytoplasmic sperm injection in a human assisted reproductive techniques program
Abstract
Objective: Laser-assisted intracytoplasmic sperm injection (LA-ICSI), also known as micro-opening or thinning of the zona pellucida (ZP) prior to ICSI, may help to reduce mechanical damage to the oocyte during the procedure. The aim of the present study was to evaluate and analyze the efficacy of our institutional LA-ICSI program, which features laser-assisted ZP thinning prior to ICSI, in comparison with conventional ICSI (C-ICSI), performed on patients with different clinical characteristics.
Methods: Patients undergoing a total of 212 ICSI cycles were randomly divided into an LA-ICSI group (106 cycles) and a conventional ICSI group (106 cycles). To reduce tissue damage, we thinned the ZP by approximately 70%, using a laser, before ICSI. Patients thus treated formed the LA-ICSI group. Comparisons included the morphological quality of transferred embryos, blastocyst development of the remaining embryos, and clinical pregnancy, in terms of ICSI method and patient characteristics.
Results: Fertilization, development of remaining embryos, and pregnancy rate were significantly higher in the LA-ICSI group compared with the C-ICSI group. Fertilization, embryonic development, and the pregnancy rate were all improved in younger patients (<38 years of age) and in those who underwent a low number of IVF-ET attempts (<3 trials). In addition, the pregnancy rate was increased in older patients.
Conclusion: LA-ICSI may be useful in improving the chance of pregnancy in all ICSI patients.
Keywords: Clinical Outcome; Human; In Vitro Fertilization-embryo Transfer; Intracytoplasmic Sperm Injection; Laser-assisted Intracytoplasmic Sperm Injection; Zona Pellucida Thinning.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Assisted sperm fusion insemination improves fertilization rates and increases usable embryos for transfer: a clinical sibling-oocyte study.F S Rep. 2024 Nov 23;6(1):17-24. doi: 10.1016/j.xfre.2024.11.006. eCollection 2025 Mar. F S Rep. 2024. PMID: 40201099 Free PMC article.
-
Laser-assisted zona pellucida thinning prior to routine ICSI.Hum Reprod. 2004 Mar;19(3):573-8. doi: 10.1093/humrep/deh093. Epub 2004 Jan 29. Hum Reprod. 2004. PMID: 14998954 Clinical Trial.
-
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007. Int J Gynaecol Obstet. 2008. PMID: 18773532 Review.
-
Evaluation and assessment of semen for IVF/ICSI.Asian J Androl. 2002 Dec;4(4):281-5. Asian J Androl. 2002. PMID: 12508129 Review.
Cited by
-
From Zygote to Blastocyst: Application of Ultrashort Lasers in the Field of Assisted Reproduction and Developmental Biology.Diagnostics (Basel). 2021 Oct 14;11(10):1897. doi: 10.3390/diagnostics11101897. Diagnostics (Basel). 2021. PMID: 34679594 Free PMC article. Review.
-
The effect of ICSI in infertility couples with non-male factor: a systematic review and meta-analysis.J Assist Reprod Genet. 2020 Dec;37(12):2929-2945. doi: 10.1007/s10815-020-01970-9. Epub 2020 Oct 19. J Assist Reprod Genet. 2020. PMID: 33073301 Free PMC article.
-
Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.Front Endocrinol (Lausanne). 2021 Aug 16;12:705733. doi: 10.3389/fendo.2021.705733. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34484119 Free PMC article.
-
Unlocking the potential of embryos: insight of systematic review and meta-analysis into laser-assisted hatching's role in conquering recurrent implantation failure.Front Reprod Health. 2025 May 9;7:1581529. doi: 10.3389/frph.2025.1581529. eCollection 2025. Front Reprod Health. 2025. PMID: 40417057 Free PMC article.
-
Thoughts on the popularity of ICSI.J Assist Reprod Genet. 2021 Jan;38(1):101-123. doi: 10.1007/s10815-020-01987-0. Epub 2020 Nov 6. J Assist Reprod Genet. 2021. PMID: 33155089 Free PMC article. Review.
References
-
- Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340:17–18. - PubMed
-
- Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oocyte activation failure after ICSI can be overcome by a modified injection technique. Hum Reprod. 2004;19:1837–1841. - PubMed
-
- Ola B, Afnan M, Sharif K, Papaioannou S, Hammadieh N, Barratt CL. Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safety. Hum Reprod. 2001;16:2485–2490. - PubMed
-
- Oehninger S, Gosden RG. Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod. 2002;17:2237–2242. - PubMed
-
- Bhattacharya S, Hamilton MP, Shaaban M, Khalaf Y, Seddler M, Ghobara T, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet. 2001;357:2075–2079. - PubMed
LinkOut - more resources
Full Text Sources